Trellus Health plc
TRLS.L · LSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | £1 | £7 | £20 | £85 |
| - Cash | £4 | £12 | £19 | £32 |
| + Debt | £0 | £0 | £0 | £0 |
| Enterprise Value | -£3 | -£5 | £0 | £53 |
| Revenue | £0 | £0 | £0 | £0 |
| % Growth | 500% | 5.6% | -28% | – |
| Gross Profit | £0 | £0 | £0 | £0 |
| % Margin | 100% | 100% | 100% | 100% |
| EBITDA | -£7 | -£6 | -£8 | -£6 |
| % Margin | -6,281.6% | -34,194.7% | -45,966.7% | -23,480% |
| Net Income | -£8 | -£6 | -£9 | -£6 |
| % Margin | -6,826.3% | -33,363.2% | -48,944.4% | -23,608% |
| EPS Diluted | -0.048 | -0.039 | -0.055 | -0.045 |
| % Growth | -23% | 28.1% | -21.7% | – |
| Operating Cash Flow | -£7 | -£5 | -£9 | -£5 |
| Capital Expenditures | -£1 | -£2 | -£3 | -£4 |
| Free Cash Flow | -£8 | -£8 | -£12 | -£8 |